Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 168-174

Karger

Access to resources Recommend Favorite

Use of Palliative Endocrine Therapy in Patients with Hormone Receptor-Positive Distant Metastatic Breast Cancer: How Often, How Effective, How Long?

By  

Oncology, Vol. 90, Iss. 1, 2016-0 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Neoadjuvant Therapy for HER2-positive Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 12, Iss. 2, 2017-05 ,pp. : 81-92

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor‐2‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 844-853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Critical Appraisal of Primary Systemic Endocrine Therapy in Receptor-Positive Postmenopausal Breast Cancer: An Update

By  

Oncology Research and Treatment, Vol. 29, Iss. 5, 2006-05 ,pp. : 210-217

Karger

Access to resources Recommend Favorite